G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 5, Pages -
Publisher
Springer Nature
Online
2018-04-27
DOI
10.1038/s41419-018-0504-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion
- (2017) Dan Yue et al. NEOPLASIA
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Arginine Demethylation of G3BP1 Promotes Stress Granule Assembly
- (2016) Wei-Chih Tsai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Choosing the right cell line for renal cell cancer research
- (2016) Klaudia K. Brodaczewska et al. Molecular Cancer
- Prognostic value of interleukin-6 and interleukin-6 receptor in organ-confined clear-cell renal cell carcinoma: a 5-year conditional cancer-specific survival analysis
- (2015) Qiang Fu et al. BRITISH JOURNAL OF CANCER
- Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients
- (2015) Lingqiang Min et al. HISTOPATHOLOGY
- Interleukin-6 as an emerging regulator of renal cell cancer
- (2015) Katarzyna Kamińska et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- C1QBP Negatively Regulates the Activation of Oncoprotein YBX1 in the Renal Cell Carcinoma As Revealed by Interactomics Analysis
- (2014) Yong Wang et al. JOURNAL OF PROTEOME RESEARCH
- Interleukin-6 in renal disease and therapy
- (2014) S. A. Jones et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1
- (2014) N Oi et al. ONCOGENE
- Downregulation of G3BPs inhibits the growth, migration and invasion of human lung carcinoma H1299 cells by suppressing the Src/FAK-associated signaling pathway
- (2013) H Zhang et al. CANCER GENE THERAPY
- Targeted therapy in metastatic renal carcinoma
- (2013) Jane Mattei et al. CANCER LETTERS
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- GAP161 targets and downregulates G3BP to suppress cell growth and potentiate cisplaitin-mediated cytotoxicity to colon carcinoma HCT116 cells
- (2012) Hao Zhang et al. CANCER SCIENCE
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression
- (2012) Toshiki Oguro et al. EUROPEAN JOURNAL OF CANCER
- Both G3BP1 and G3BP2 contribute to stress granule formation
- (2012) Hideaki Matsuki et al. GENES TO CELLS
- A Novel 19q13 Nucleolar Zinc Finger Protein Suppresses Tumor Cell Growth through Inhibiting Ribosome Biogenesis and Inducing Apoptosis but Is Frequently Silenced in Multiple Carcinomas
- (2012) Y. Cheng et al. MOLECULAR CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The Epidemiology of Renal Cell Carcinoma
- (2011) Börje Ljungberg et al. EUROPEAN UROLOGY
- Arginine methylation of G3BP1 in response to Wnt3a regulates -catenin mRNA
- (2011) R. K. Bikkavilli et al. JOURNAL OF CELL SCIENCE
- Revisiting G3BP1 as a RasGAP Binding Protein: Sensitization of Tumor Cells to Chemotherapy by the RasGAP 317–326 Sequence Does Not Involve G3BP1
- (2011) Alessandro Annibaldi et al. PLoS One
- A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
- (2010) J-F Rossi et al. BRITISH JOURNAL OF CANCER
- mTOR Complex Component Rictor Interacts with PKC and Regulates Cancer Cell Metastasis
- (2010) F. Zhang et al. CANCER RESEARCH
- Long-term management of patients with metastatic renal cell carcinoma on targeted agents
- (2010) Eric Jonasch et al. Expert Review of Anticancer Therapy
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
- (2009) F. Colotta et al. CARCINOGENESIS
- Targeting Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma
- (2009) Z. S. Morris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma
- (2008) Jacob A. Klapper et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now